MedPath

Acupuncture for weight loss and mental health

Not Applicable
Completed
Conditions
Overweight and Obesity
Mental Health - Other mental health disorders
Alternative and Complementary Medicine - Other alternative and complementary medicine
Diet and Nutrition - Obesity
Registration Number
ACTRN12612000896875
Lead Sponsor
Victoria Univeristy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
39
Inclusion Criteria

Inclusion criteria included: a BMI of 25 to 40 at enrollment of the study (all participants’ commenced treatment within four weeks of enrolling); stable body weight three months prior to enrolling in the study and the ability to give written informed consent.

Exclusion Criteria

Participants were excluded if they were: less than 18 years of age; seeking other weight loss treatment outside the study; diagnosed with a serious concomitant illness such as heart disease or endocrine disease; pregnant or had given birth within the last six months; diagnosed with Polycystic Ovarian Syndrome or provided with medical treatment that may have had nutritional implications on weight or appetite or their ability to comply with the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure was body weight change (kg and percentage).[Body weight was measured weekly (1-6 and then 8-14), on digital scales (Tanita, USA) in kilograms with 0.1kg graduations.]
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measures were the validated Eating Disorder Inventory-3 (EDI-3, EDRC scale).[Each questionnaire was administered prior to randomisation, at the completion of the first phase of treatment and at the beginning and end of the second phase of treatment.];the Becks Depression Inventory (BDI-2).[Each questionnaire was administered prior to randomisation, at the completion of the first phase of treatment and at the beginning and end of the second phase of treatment.];the State-Trait Anxiety Inventory (STAI).[Each questionnaire was administered prior to randomisation, at the completion of the first phase of treatment and at the beginning and end of the second phase of treatment.];the SF-36v2 Health Survey (physical and mental quality of life).[Each questionnaire was administered prior to randomisation, at the completion of the first phase of treatment and at the beginning and end of the second phase of treatment.]
© Copyright 2025. All Rights Reserved by MedPath